IgM Myeloma: A Multicenter Retrospective Study of 159 Patients

Introduction: IgM-secreting myeloma is rare, encompassing about 1% of all the myeloma cases. Given its rarity, the characteristics and survival of these patients have not been extensively studied. Therefore, we carried out a multicenter retrospective study in patients with IgM myeloma. Methods: The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BLOOD 2016-12, Vol.128 (22), p.3276-3276
Hauptverfasser: Castillo, Jorge J., Jurczyszyn, Artur J., Crusoe, Edvan, Czepiel, Jacek, Davila, Julio, Dispenzieri, Angela, Eveillard, Marion, Fiala, Mark A, Ghobrial, Irene M., Gozzetti, Alessandro, Gustine, Joshua, Hájek, Roman, Hungria, Vânia, Jarkovsky, Jiri, Jayabalan, David, Laubach, Jacob P., Lewicka, Barbara, Maisnar, Vladimir, Manasanch, Elisabeth E., Moreau, Philippe, Nahi, Hareth, Niesvizky, Ruben, Paba-Prada, Claudia E., Pika, Tomas, Pour, Ludek, Reagan, John L, Richardson, Paul G, Shah, Jatin J., Spicka, Ivan, Vij, Ravi, Waszczuk, Anna, Gertz, Morie A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: IgM-secreting myeloma is rare, encompassing about 1% of all the myeloma cases. Given its rarity, the characteristics and survival of these patients have not been extensively studied. Therefore, we carried out a multicenter retrospective study in patients with IgM myeloma. Methods: The study protocol was reviewed and approved by the Institutional Review Board of each participating institution. Clinical data were gathered and included age, sex, hemoglobin, calcium, LDH, estimated glomerular filtration rate (GFR), presence of lytic bone lesions, International Staging System score, cytogenetic abnormalities, final outcome and overall survival (OS) time. OS was defined as the time in months from diagnosis to last follow-up or death. The Chi-square and the rank-sum tests were used to compare categorical and continuous variables, respectively. The Kaplan-Meier method was used to estimate OS and the log-rank waas used to compare groups. The Cox proportional-hazard regression method was used to fit univariate and multivariate survival models, reported as hazard ratio (HR) with 95% confidence intervals (CI). All reported p-values are two-sided, and were considered significant if less than 0.05. Results: A total of 159 patients with IgM myeloma from 20 centers from Europe, USA and Latin America were included in this analysis. Patients were diagnosed between 1996 and 2015. The median age at diagnosis was 65 years (range 37-86 years) with a male predominance (68%). The median serum IgM level was 2510 mg/dl (range 27-12,100 mg/dl) with 25% of patients having a serum IgM within normal limits but an IgM monoclonal spike detectable in serum electrophoresis. Hemoglobin levels
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V128.22.3276.3276